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Background: Small-cell neuroendocrine carcinoma (SCNEC) of the head and neck is rare. The prognosis of SCNEC
in the nasal cavity and larynx is poor. The aim of this study was to investigate the clinicopathological features of
nasal and laryngeal SCNEC and to determine the expression of HIF-1α, GLUT-1, PI3K, and p-Akt in SCNEC.
Methods: Between 2003 and 2012, 10 consecutive patients with histologically demonstrated nasal and laryngeal SCNEC
were enrolled. Clinicopathological materials and follow-up data were analyzed retrospectively. Immunohistochemistry
was used to detect GLUT-1, HIF-1α, PI3K, and p-Akt expression in paraffin wax-embedded tumor specimens.
Results: The subjects were eight males and two females with a mean age of 60.8 (range: 53 to 71) years. Tumors were
located in the maxillary sinus (n = 3) and larynx (n = 7). At last follow-up, four patients (40.0%) had local recurrence and
five patients (50.0%) had developed distant metastases. Six patients died. The mean overall survival was 19.3 ± 2.1 months.
Expression of GLUT-1, HIF-1α, PI3K, and p-Akt was seen in sinonasal and laryngeal SCNEC in 80 (8 out of 10), 50 (5 out of
10), 40 (4 out of 10), and 40% (4 out of 10) of cases, respectively. Expression of GLUT-1, HIF-1α, PI3K, and p-Akt
was higher in sinonasal and laryngeal SCNEC than in precancerous lesions.
Conclusions: Primary sinonasal and laryngeal SCNEC is rare. This paper presents 10 cases of sinonasal and
laryngeal SCNEC with more common local recurrence and distant metastasis. HIF-1α, GLUT-1, PI3K, and p-Akt expression
was higher in sinonasal and laryngeal SCNEC than in precancerous lesions.
Keywords: Small-cell neuroendocrine carcinoma, Larynx, Nasal cavity and paranasal sinuses, Hypoxia-inducible factor-1α,
Glucose transporter-1, PI3K/Akt pathwayBackground
Small-cell neuroendocrine carcinoma (SCNEC) of the
head and neck is rare. Approximately 180 cases of the
larynx and 75 cases of nasal and paranasal cavities have
been reported in the English literature [1]; these were
mostly in males around 50-years-old and heavy smokers
[1-3]. The prognosis of SCNEC in the nasal cavity and
larynx is poor. Extra-pulmonary small-cell carcinoma is
usually a fatal disease, with a 13% five-year survival rate
[4]. In the larynx, the two-year survival rate was 16%* Correspondence: zhouyunzhoush@163.com
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unless otherwise stated.and the five-year rate was only 5% [5]. In the nasal cavity
and sinus, the median survival time was two to three
years [6]. The survival rates are similar to those for
small-cell lung cancer. Unfavorable prognostic factors of
SCNEC in the head and neck show a correlation with an
invasion of the lamina cribrosa [7], ectopic hormone syn-
drome [8], recurrence, and distant metastasis [5]. However,
tumor size and number of mitoses show no correlation
with recurrence, metastasis, or survival [5]. Conclusive
prognostic factors remain unclear because of the limited
number of SCNEC cases in the head and neck. Thus, prog-
nostic factors need further study using a greater numbers
of cases of SCNEC in the head and neck.
Some studies have investigated the prognostic factors
for SCNEC, looking at molecular markers, such asd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studied in neuroendocrine carcinoma (NEC) [9,10].
Hypoxia in solid tumors has been associated with ther-
apy resistance and poor clinical prognosis [9,10]. HIF-
1α is upregulated in a wide range of solid tumors in
humans, and over-expression of HIF-1α is associated
with tumor aggressiveness and poor prognosis [9,10].
In small-cell lung cancer, a few studies have revealed
that high levels of HIF-1α is correlation with poor sur-
vival [9,10]. GLUT-1, a major protein of cellular glu-
cose uptake, has been studied in NEC [11]. Hypoxia
promotes the chemo-radioresistance of carcinomas [12]
and GLUT-1 is overexpressed in a hypoxic environment
[13]. HIF-1α, a transcription factor associated with the cel-
lular response to hypoxia [14], upregulates the expression
of several hypoxia response genes, including GLUT-1.
We have previously reported that there is a significant
correlation between GLUT-1 and HIF-1α expression in
laryngeal carcinoma [15], and there is further evidence
thatthe phosphatidylinositol 3-kinase (PI3K)/protein kin-
ase B (Akt) pathwaymay regulate HIF-1α and GLUT-1
[16]. To the best of our knowledge, there is no previous
report of these hypoxic markers in NEC.
In the present study, we retrospectively investigated
the clinicopathological features of nasal and laryngeal
SCNEC. We also used immunohistochemistry to deter-
mine the expression of HIF-1α, GLUT-1, PI3K, and p-Akt
protein in these SCNEC.
Methods
Patients
The subjects were 10 consecutive patients at The First
Affiliated Hospital with histologically demonstrated sino-
nasal and laryngeal SCNEC between 2003 and 2012, and
15 sinonasal and laryngeal precancerous lesions were
also obtained as a control group. Data were obtained
from the hospital surgical pathology files.
Our study was approved by the Institutional Review
Board of The First Affiliated Hospital, College of Medicine,
Zhejiang University. Written informed consent was ob-
tained from each patient before inclusion in the study.
Immunohistochemistry
Formalin-fixed and paraffin wax-embedded tissue blocks
from primary lesions were cut into 4-μm sections, and rep-
resentative sections were analyzed using immunohistochem-
istry (EliVision Plus IHC kit; Fuzhou Maixin Biotechnology
Development Co., Ltd., Fuzhou, China), using Ki-67 (mouse,
clone MIB 1, DAKO, Glostrup, Denmark) at a dilution of
1:400, a rabbit polyclonal antibody against GLUT-1
(1:50, Santa Cruz Biotechnology, Dallas, USA.), a mouse
monoclonal antibody against HIF-1α (1:100; Santa Cruz
Biotechnology Dallas, USA.), a rabbit monoclonal anti-
body against PI3K (1:100, Santa Cruz Biotechnology Dallas,USA.), and a rabbit polyclonal antibody against p-AKT
(1:50, Santa Cruz Biotechnology, Dallas, USA.). Briefly, the
sections were deparaffinized with xylene and dehydrated
through an ethanol series. Then, antigen retrieval was per-
formed with a microwave oven over two 10-min cycles.
Endogenous peroxidase activity was blocked by incubating
the slidesin 1.5% hydrogen peroxide in absolute methanol
at room temperature for 10 minutes. Primary antibodies
were applied for 1 hour at room temperature, followed by
50 μL of polymer enhancer for 20 minutes and 50 μL of
polymerized horseradish peroxidase-anti-mouse immuno-
globulin G (IgG) (DAB Kit; Maixin Biological Company,
FuZhou, City, China) for 30 minutes. The reaction prod-
ucts were visualized using 3,3’-Diaminobenzidine (DAB
Kit; Maixin Biological Company, FuZhou, City, China),
and the sections were counterstained with hematoxylin
and eosin, dehydrated, and examined under a light micro-
scope. Tris-buffered saline was used in place of the primary
antibody for negative controls.
Ki-67, GLUT-1, HIF-1α, PI3K, and p-Akt levels were
evaluated by the same investigator (QH You), who was
blinded tothe clinicaland follow-up data. GLUT-1 ex-
pression was considered positive only if distinct mem-
brane staining was present. HIF-1α, PI3K, and p-AKT
proteins were observed in the nucleus and cytoplasm.
Protein analysis was performed in 10 random high-power
fields,with 100 tumor cells counted within each field for
each case and for all antibodies. The percentage of positive
cells was calculated by dividing the number of positive
tumor cells by the total number of tumor cells counted.
A sample was considered negative if less than 25% of
the cells were stained.Follow-up
The patients were scheduled for follow-up visits every
three months after the initial surgery. Follow-up con-
sisted of a routine physical examination and a computed
tomography (CT) or magnetic resonance imaging (MRI)
scan of the primary site. Patient follow-up was reported
up to the date they last seen in the clinic.Statistical analysis
The SPSS software (version 20 for Windows; SPSS Inc.,
Chicago, Illinois, United States) was used to conduct all
statistical tests. Associations among GLUT-1, HIF-1α,
PI3K, and p-Akt protein expression and pretreatment
clinical parameters were analyzed using the chi-squared
and Fisher’s exact tests. Overall survival (OS), defined as
the time from surgery until death from any cause, was plot-
ted as a Kaplan-Meier curve. Univariate survival analysis
was performed using a log-rank test, and multivariate ana-
lysis was performed using Cox proportional-hazards re-
gression analysis. A P value of less than 0.05 was deemed
Table 1 Clinicopathological findings and expression of hypoxic markers
pt Sex Age
(years)





TNM Treatment Recurrence Metastasis Follow-up GLUT-1 HIF-1 p-Akt PI3K




and bleeding, no smoking
2 months T2N0M0 right partial maxillectomy and
postoperative radiotherapy
yes No DOD 22 months pos neg pos neg
2 M 56 2 left nasal and
maxillary sinus
left nasal obstruction and
left face numb, 20 cigarettes
perday for over 40 years
1 month T4N0M0 CCRT yes yes DOD 22 months pos neg neg neg
3 M 50 3 supraglottis odynophagia, hoarseness,
40 cigarettes per day for over
15 years
2 months T2N0M0 partial laryngectomy,
postoperative CCRT
no no alive 26 months pos pos pos neg
4 F 71 4 subglottis hoarseness, no smoking 8 years T2N0M0 total laryngectomy no no alive 22 months pos pos neg pos
5 M 67 5 supraglottis a progressively enlarging mass
in the right side of the neck,
20 cigarettes per day for over
20 years
1 month T2N2M0 total laryngectomy and
bilateral neck dissection,
postoperative CCRT
no yes DOD 12 months pos neg neg pos
6 M 59 6 supraglottis odynophagia, no smoking 2 years T1N0M0 partial laryngectomy,
postoperativeCCRT
yes yes DOD 18 months pos pos pos neg
7 M 58 7 subglottis progressive hoarseness ,
40 cigarettes per day for
over 20 years
3 months T2N2M0 total laryngectomy + right
neck dissection
no yes DOD 6 months neg neg neg neg
8 M 53 8 supraglottis hoarseness, 20 cigarettes
perday for over 30 years
2 months T2N0M0 partial laryngectomy,
postoperative CCRT
no no alive 8 months neg neg neg pos
9 M 66 9 supraglottis odynophagia, foreign body
feeling, 20 cigarettes per day
for over 20 years
2 years T2N0M0 partial laryngectomy + bilateral
neck dissection, postoperative
CCRT
no no alive 1 months pos pos pos neg
10 F 64 10 right nasal and
ethmoid sinus
left nasal obstruction, no
smoking
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was performed using Spearman’s rank correlation.
Results and discussion
Clinicopathological findings
Clinicopathological findings are shown in Table 1. The
subjects included eight males and two females with a
mean age of 60.8 (range: 53 to71) years. Tumors were
located in the maxillary sinus (n = 3, 30%) and the larynx
(n = 7, 70%). In the larynx, five cases were located in the
supraglottic area and two in the subglottic area. No pa-
tient presented with paraneoplastic endocrine syndrome.
Radiological images
The SCNEC radiological images available varied. CT images
were available for eight patients and showed homogenous
(two cases) and heterogeneous (six cases) soft-tissue masses.
Contrast-enhanced CT images were available for eight pa-
tients: mild enhancement was found in the two cases of la-
ryngeal SCNEC and strong enhancement in six cases (one
in the nasal cavity, five in the larynx; Figures 1, 2, 3 and 4).
MRI data were available for four patients (two in the
nasal cavity and two in the larynx). In four patients,
the T1-weighted signals and the T2-weighted signals
were hyperintense. Contrast-enhanced T1-weighted MRI
images showed strong enhancement in all four patients.
Diffusion-weighted MRI (DWI) was available for two
patients. The DWI in two patients was high-signal and
the apparent diffusion coefficient (ADC) was 0.793 ±
0.33 × 10−3 mm2/s (laryngeal SCNEC) and 1.78 ± 0.16 ×
10−3 mm2/s, respectively (Figures 5, 6, 7 and 8).
Treatment and follow-up
In nasal SCNEC, two patients received concurrent chemo-
radiotherapy (CCRT) and one patient received partial max-
illectomy and postoperative radiotherapy. Three patientsFigure 1 CT of the sinonasal small-cell neuroendocrine carcinoma of
maxillary sinus involving the right nasal cavity, right ethmoid sinus, and sph
strongly enhanced.developed local recurrence and two patients developed
distant metastasis. Three patients died at 22, 22, and
20 months after diagnosis. In larynx SCNEC, four pa-
tients underwent horizontal supraglottic laryngectomy
and one patient received bilateral neck dissection sim-
ultaneously. All four patients received postoperative
CCRT. One patient was alive at over 26 months. Two pa-
tients were followed for only 1 and 6 months after surgery.
One patient suffered a local recurrence 14 months after
initial surgery and underwent a total laryngectomy and bi-
lateral neck dissection and postoperative radiotherapy.
The patient died 18 months after the first surgery due to
distant metastasis. Three patients underwent total laryn-
gectomies. One patient received bilateral neck dissection
and postoperative CCRT. He died 12 months after sur-
gery. One received a unilateral neck dissection and died
7 months after diagnosis due to a distant metastasis. An-
other patient received 14-Gy postoperative radiotherapy.
However, she did could not tolerate the side effects of
radiotherapy and abandoned it. She was disease-free after
22 months of follow-up. In this small series, the mean
overall survival (OS) was 19.3 ± 2.1 months and the two-
year survival rate was 25.4%.
Immunohistochemical findings
The Ki-67 index was 25% in one patient, 30% in two pa-
tients, 45% in three patients and higher than 70% in
four.The cutoff of the Ki-67 for the diagnosis of small-
cell carcinomaswas 50%. Expression of GLUT-1, HIF-1α,
PI3K, and p-Akt was seen in sinonasal and laryngeal
SCNEC in 80 (8 out of 10), 50 (5 out of 10), 40 (4 out of
10), and 40% (4 out of 10) of cases, respectively (Table 1,
Figure 9). Expression of GLUT-1, HIF-1α, PI3K, and p-Akt
in control precancerous lesions was seen in 6.7 (1 out of
15), 0 (0 out of 15), 0 (0 out of 15), and 0% (0 out of 15)
cases, respectively. The expression of GLUT-1, HIF-1α,Case 1. a) Noncontrast axial CT showing a soft-tissue mass in the right
enoid sinus. b) Contrast-enhanced CT showing that the lesion was
Figure 2 CT of laryngeal small-cell neuroendocrine carcinoma of Case 3. a) Noncontrast axial CT showing a heterogeneous irregular soft-tissue
mass in the right supraglottic region involving the right vocal cord. b) Contrast-enhanced CT showingthat the lesion was heterogeneous enhanced
and the thyroid cartilage was not involved.
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SCNEC than in precancerous lesions (P = 0.001, 0.005,
0.017, and 0.017, respectively). Of the five patients who
died, five (100%) were positive for GLUT-1 and two (40%)
were positive for HIF-1α, PI3K, and p-Akt.
In this small series, univariate analysis showed that
poor survival was significantly associated with distant
metastasis (χ2 = 4.97, P = 0.026). Ki-67, GLUT-1, HIF-
1α, PI3K, and p-Akt expression were not correlated
with survival.In a multivariate analysis,these markers
were not predictors of OS.
Sinonasal and laryngeal SCNEC typically presents thera-
peutic challenges, and specific etiological factors andFigure 3 CT of laryngeal small-cell neuroendocrine carcinoma of Case
tissue mass in the subglottic regionnot involving the bilateral vocal cord
lesion was mildly enhanced.prognostic factors remain unknown due their extreme
rarity. Nasal and laryngeal SCNEC is the most aggres-
sive and has a poor prognosis. Unlike other reports of
sinonasal NEC, which is most common in the ethmoid
sinuses [3], in our series, all three sinonasal tumors
were located in the maxillary sinus. In the larynx, five
cases were located in the supraglottic area and two in
the subglottic area. There was a male predominance,
with a male/female ratio 4:1, and a mean age of 60.8
(range: 53 to 71) years. Seven patients were heavy smokers.
The mean duration of symptoms at presentation was
16.7 months (range: 1 month to 8 years). In another
report of 16 cases of NEC in the head and neck, the4. a) Noncontrast axial CT showing a heterogeneous well-defined soft-
and laryngeal cartilages. b) Contrast-enhanced CT showing that the
Figure 4 CT of laryngeal small-cell neuroendocrine carcinoma of Case 9. a) Noncontrast axial CT showing a small well-defined soft-tissue
mass in the left epiglottic base not involving the bilateral vocal cord and laryngeal cartilages. b) Contrast-enhanced CT showing that the lesion
was strongly enhanced. c) Laryngostroscopy showing a red smooth mass in the laryngeal surface of epiglottis.
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65.8 (range: 43 to 88) years. Of those, 11 (68.8%) had
smoked cigarettes (mean pack-years: 50.5; range: 15 to
116) [17].
CT or MRI imaging of the head and neck are more
useful than conventional radiography when assessing the
extent of the local invasion of the tumor and are better
for the planning of further treatment [6]. In our series,
CT scans showed heterogeneous soft-tissue masses in
most cases and a mass in the right maxillary sinus
extending to the right nasal cavity in one case. Contrast-
enhanced CT images showed that the lesions had dif-
fering degrees of enhancement. An MRI scan improves
differentiation between inflammatory reaction, tumor,
and liquid retention. The combination of DWI and ADC
may differentiate malignant tumors from precancerous
lesions and benign tumors [18]. In the present study,
the T1-weighted signals and the T2-weighted signals were
hyperintense. Indeed, contrast-enhanced T1-weightedFigure 5 MRI of Case 2 showingan abnormal signal in the left maxilla
signals were hypointense, b) the T2-weighted signals were hyperintense, c
strong enhancement.MRI images showed a strong enhancement. We first
reported DWI and ADC values in head and neck SCNEC.
We found high DWI and low ADC values in laryngeal
SCNEC compared with our previous findings [18]. Future
studies with larger patient populations are recommended
to further evaluate the role of DWI in head and neck
NEC.
The treatment of sinonasal and laryngeal SCNEC is
controversial. Surgery, radiotherapy, and chemotherapy
alone, or in combination, have been used for sinonasal
SCNEC [16]. In the present study, two of the three pa-
tients with sinonasal SCNEC received CCRT and one pa-
tient received surgery and postoperative radiotherapy.
Three patients died within two years.In the 1980s, sur-
gery followed by radiotherapy was the routine thera-
peutic strategy for sinonasal SCNEC [19]. Since the late
1990s, a combination of chemotherapy and radiotherapy,
with or without surgery, has been recommended [6]. Re-
garding the treatment of laryngeal SCNEC, most authorsry sinus, left nasal cavity, and nasopharynx. a) TheT1-weighted
) and the contrast-enhanced T1-weighted MRI images show
Figure 6 Laryngostroscopy and MRI of Case 7. a) Laryngostroscopy showed that there was a red smooth mass in the right subglottic area. An
MRI scan revealed that there was a mass in the right subglottic area. b) TheT1-weighted signals, c) and the T2-weighted signals were hyperintense,
d) and the contrast-enhanced T1-weighted MRI images show strong enhancement.
Chai et al. World Journal of Surgical Oncology 2014, 12:199 Page 7 of 10
http://www.wjso.com/content/12/1/199generally agree that surgery, alone or in combination
with radiotherapy, does not improve local tumor control
[2]. Baugh et al. found that the combination of primary
radiation therapy and adjuvant chemotherapy resulted in
relative good prognosis through comparison of various
previously reported therapeutic modalities for laryngeal
SCNEC [20]. However, this review was published in 1986
and concerned approximately 50 cases. Since then, there
has been no large series report of laryngeal SCNEC and
there is no review or meta-analysis of the treatment of la-
ryngeal SCNEC. Thus, no standard therapeutic modality
has yet been determined for laryngeal SCNEC. In the
present study, four patients underwent partial laryngecto-
mies plus postoperative CCRT and three patients under-
went total laryngectomy. Two patients died of distant
metastases. The other six patients were alive, but the
follow-up duration is insufficient.
Extra-pulmonary small-cell carcinoma has a dismal
prognosis, with a 13% five-year survival rate [4]. The
prognosis of sinonasal and laryngeal SCNEC is poor and
is similar to that of small-cell lung cancer (SCLC). In lar-
ynx SCNEC, the two-year survival rate was 16%, while
the five-year rate was only 5% [5]. In the nasal cavityFigure 7 Laryngostroscopy and MRI of Case 8. a) Laryngostroscopy sho
left vocal cord, anterior commission, and left aryepiglottic fold. An MRI scan
involved the left vocal cord. b) TheT1-weighted signals and c) the T2-weigh
MRI images show strong enhancement. e) DWI suggested hyperintense lesion
ADC map reveals a hypointense mass of lesions in the left false vocal cord (ADand sinus, the five-year overall survival for SCNEC is
below 30% [6]. However, the prognostic factors remain
unclear. Unfavorable prognostic factors of SCNEC in the
head and neck seem to be correlated with an invasion of
the lamina cribrosa [8], recurrence, and distant metasta-
sis [5]. In pulmonary SCNEC, ectopic hormone syndrome
may be a predictor of increased mortality due to the
higher risk of cerebral metastasis [21]. Endocrine syn-
drome also seems to worsen the prognosis in cases of
head and neck SNEC [6]. Almost 50% of the patients with
laryngeal SCNEC have positive lymph nodes at the initial
diagnosis and 90% of them develop distant metastases (for
example lymph nodes, liver, lung, bones, or bone marrow)
[22]. In the present laryngeal SCNECs, only two patients
(28.6%) had positive lymph nodes at the time of symptom
presentation. At the final follow-up, only one patient
(14.3%) had local recurrence and three patients (42.9%)
developed distant metastases, including in the liver, lung,
and cervical lymph node. Unlike laryngeal SCNEC, pa-
tients with sinonasal SCNEC had low lymph node meta-
static rates at symptom presentation. Babin et al. reported
that only three patients (14.3%) had positive lymph nodes
at the initial diagnosis [6]. In their series, 17 of 21 patientswinga red smooth mass in the left false vocal cord involving in the
revealed that there was a mass in the left false vocal cord that also
ted signals were hyperintense, d) and the contrast-enhanced T1-weighted
s were in the left false vocal cord (b = 1000s/mm2). f) The corresponding
C = 0.793 × 10−3 mm2/s).
Figure 8 MRI of Case 10 showingan abnormal signal in the right maxillary sinus and right nasal cavity. a) TheT1-weighted signals b) and
the T2-weighted signals were hyperintense c) and the contrast-enhanced T1-weighted MRI images show strong enhancement. d) DWI suggested
hyperintense lesions were in the right maxillary sinus and right nasal cavity. e) The corresponding ADC map reveals (ADC = 1.78 × 10−3 mm2/s).
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[6]. Han et al. reviewed 55 cases of sinonasal SCNEC in
the English literature [3]. They found that the overall local
recurrence rate was 33% and the metastasis rate was 31%
[3]. In 11 patients with head and neck SCNEC, Meacham
et al. found that eight patients had regional lymph node
metastases and another patient had distant metastases. Of
patients with SCNEC in the head and neck, 35.4% sur-
vived to 24 months [19]. In our series, three patients had
no metastatic cervical lymph nodes at initial diagnosis. In
our small series, the mean overall survival was 21.3 months.
A high Ki-67 index is an unfavorable sign in some NECs
[23]. An unfavorable course is observed when the Ki-67
index is higher than 5% [24]. In our study, the Ki-67 index
was higher than 25% in eight patients.However, univariateFigure 9 The expression of hypoxic markers in the sinonasal and lar
a) GLUT-1, b) HIF-1α, c) PI3K, and d) p-Akt was positive.analysis showed that poor survival was not associated with
Ki-67.
Overexpression of HIF-1αis considered to be a signifi-
cant poor prognostic factor in SCLC as well as non-
SCLC [9,10]. In SCLC, low expression of HIF-1α may be
a useful predictor of better overall survival [10]. HIF-1α
expression had an unfavorable influence on overall sur-
vival in SCLC [9]. HIF-1α upregulates expression of
GLUT-1 via the PI3K/Akt pathway [16]. GLUT-1 was
expressed in approximately half of the pulmonary NEC,
and GLUT-1 expression was associated with an increased
risk of death in pulmonary NEC [11]. Although there was
no significant difference between HIF-1α/GLUT-1/PI3K/
Akt expression and sinonasal and laryngeal SCNEC, this
is the first study of HIF-1α, GLUT-1, PI3K, and p-Aktyngeal small-cell neuroendocrine carcinoma. The expression of
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that HIF-1α, GLUT-1, PI3K, and p-Akt expression was
significant higher in sinonasal and laryngeal SCNEC than
in precancerous lesions. Of the five patients who died, five
(100%) were positive for GLUT-1 and two (40%) were posi-
tive for HIF-1α, PI3K, and p-Akt. Because of the small
number of cases in our series (n = 10), it is difficult to reach
any statistically significant conclusions regarding the prog-
nostic significance of these hypoxic markers. The effect of
the expression of these hypoxic markers on the prognosis
in sinonasal and laryngeal SCNEC requires further clarifi-
cation with a larger cohort.
Conclusions
Primary sinonasal and laryngeal SCNEC is rare. In our
case series, laryngeal SCNEC was more common. Sinona-
sal and laryngeal SCNEC present with common local re-
currence and distant metastasis. CT and MRI scans may
aid in the diagnosis and assessment of the extent of local
invasion. The mean overall survival was 19.3 months in 10
sinonasal and laryngeal SCNEC cases.The best treatment
of sinonasal and laryngeal SCNEC is still unclear. HIF-1α,
GLUT-1, PI3K, and p-Akt expression was significant
higher in sinonasal and laryngeal SCNEC than insino-
nasal and laryngeal precancerous lesions. An examin-
ation of a larger series is required to identify prognostic
factors and formulate appropriate therapeutic strategies.
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